|Podcasts|December 9, 2022
Achieving Success in the Rare Disease Space
Author(s)Nicholas Saraceno, Senior Editor
Lessons learned around commercializing new products in this niche sector
Advertisement
Andy Udell, North American president at Calliditas Therapeutics, a specialty pharma company, uncovers the complexities surrounding rare disease product commercialization, while also shedding light on outreach strategies that help spread awareness of new medications.
The latest episode of The Pharmaceutical Commerce Podcast is available directly on SoundCloud.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
How Rising Cargo Theft Puts New Pressure on the Pharma Supply Chain
2
Gregg Gorniak on Turning DSCSA Compliance Investment Into Shared Value
3
Ameer Ali on Why NDC-12 Readiness Can't Wait
4
The Proprietary LLM Behind ClaimGuardRx's Detect-and-Respond Engine
5